CME webinar: Behavioral Health in Primary Care: How UPMC Health Plan Can Help

Jan. 2022Education/Webinars
"Please join us for a live, CME-accredited webinar Thursday, March 10, from noon to 1 p.m.

The presentation will include an overview of behavioral health in primary care, including the following topics:
  • Background, prevalence, and best practices
  • Available supports and services at UPMC Health Plan such as the RxWell app, behavioral health condition management, and case management
  • How to prescribe these and other UPMC Health Plan supports and services with UPMC Prescription for Wellness
  • Reimbursement and potential incentives for depression screening

Presented by:
  • Alin Severance, MD, Medical Director, Behavioral Health Services at UPMC Health Plan; Associate Medical Director, Community Care Behavioral Health Organization
  • Jamie Delu, RRT, Director, Prescription for Wellness at UPMC Health Plan
  • Laura Francis, MSW, LSW, Program Director, Behavioral Integration at UPMC Health Plan
  • Rebecca Knoll, MPH, Director, Quality Provider Performance at UPMC Health Plan
  • Tanuja Tripurana, BTech in Mechanical Engineering, Senior Manager, RxWell at UPMC Health Plan

Register now at upmchp.us/bhpc. This webinar will be recorded.

You may earn continuing medical education (CME) credits for attending this webinar.*

*Provider is responsible for verifying CME eligibility. This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, and ASWB. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."

Recent Announcements

Watch for a chance to rate your experience with UPMC Health Plan

Watch for a chance to rate your experience with UPMC Health Plan. You may be randomly selected to participate in a 2026 Press Ganey provider satisfaction survey that will begin this month.
Aug. 2026Important Notices

Voluntary nationwide recall: Cetirizine (Unique – July)

Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.
Jul. 2026Pharmacy Updates

August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates

Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.
Jul. 2026Pharmacy Updates